Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Digestive Disorder

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1774871

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1774871

Gastrointestinal Diagnostics

PUBLISHED:
PAGES: 478 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Gastrointestinal Diagnostics Market to Reach US$5.8 Billion by 2030

The global market for Gastrointestinal Diagnostics estimated at US$4.9 Billion in the year 2024, is expected to reach US$5.8 Billion by 2030, growing at a CAGR of 2.8% over the analysis period 2024-2030. Endoscopy Test, one of the segments analyzed in the report, is expected to record a 2.2% CAGR and reach US$1.6 Billion by the end of the analysis period. Growth in the Blood Test segment is estimated at 1.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.3 Billion While China is Forecast to Grow at 5.1% CAGR

The Gastrointestinal Diagnostics market in the U.S. is estimated at US$1.3 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.1 Billion by the year 2030 trailing a CAGR of 5.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.1% and 2.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.5% CAGR.

Global Gastrointestinal Diagnostics Market - Key Trends & Drivers Summarized

How Are Advancements in Gastrointestinal Diagnostics Improving Disease Detection?

Gastrointestinal (GI) diagnostics have witnessed significant advancements in recent years, driven by the increasing prevalence of GI disorders and the need for early and accurate disease detection. Conditions such as inflammatory bowel disease (IBD), colorectal cancer, peptic ulcers, gastroesophageal reflux disease (GERD), and celiac disease require timely and precise diagnostic tools to ensure effective treatment. Traditional diagnostic methods such as endoscopy, colonoscopy, and stool analysis remain the cornerstone of GI disease detection, but emerging technologies are enhancing diagnostic accuracy, reducing procedure times, and improving patient outcomes.

Recent innovations in GI diagnostics include capsule endoscopy, molecular biomarker testing, and artificial intelligence (AI)-assisted imaging. Capsule endoscopy enables non-invasive visualization of the entire digestive tract, particularly the small intestine, which is difficult to assess using conventional endoscopy. AI-powered diagnostic tools are improving the detection of precancerous lesions, polyps, and other abnormalities in endoscopic images, reducing the risk of human error. Furthermore, advancements in liquid biopsy and microbiome analysis are enabling personalized diagnostics, helping physicians tailor treatment strategies based on individual patient profiles. As these technologies continue to evolve, gastrointestinal diagnostics are becoming more accessible, efficient, and precise.

Which GI Diagnostic Technologies Are Driving Market Growth?

The demand for advanced gastrointestinal diagnostics is growing across multiple healthcare settings, including hospitals, diagnostic laboratories, and ambulatory care centers. Endoscopy remains the gold standard for diagnosing GI disorders, but new imaging modalities such as confocal laser endomicroscopy (CLE) and fluorescence endoscopy are enhancing the ability to detect mucosal abnormalities in real time. High-resolution manometry (HRM) is also being increasingly adopted for diagnosing esophageal motility disorders, providing valuable insights into swallowing dysfunction and reflux-related conditions.

Molecular diagnostics and genetic testing are also playing a growing role in the early detection of gastrointestinal cancers and hereditary GI diseases. Next-generation sequencing (NGS) enables precise identification of genetic mutations linked to conditions such as Lynch syndrome and hereditary pancreatitis, allowing for proactive disease management. Additionally, the rise of point-of-care testing (POCT) for GI infections, such as Helicobacter pylori and Clostridium difficile, has improved rapid diagnosis and treatment initiation. With the increasing focus on non-invasive and minimally invasive diagnostics, the GI diagnostics market is poised for substantial expansion in the coming years.

What Are the Latest Technological Advancements in Gastrointestinal Diagnostics?

Technological innovations are transforming gastrointestinal diagnostics by enhancing detection capabilities, reducing procedure times, and improving patient comfort. One of the most significant breakthroughs is the integration of AI into endoscopic and imaging procedures. AI algorithms can analyze endoscopic videos in real time, identifying abnormalities such as polyps, tumors, and inflammation with high accuracy. This technology is helping endoscopists detect early-stage colorectal cancer and precancerous lesions more effectively, reducing the incidence of missed diagnoses.

Additionally, liquid biopsy is emerging as a revolutionary tool for non-invasive GI cancer detection. By analyzing circulating tumor DNA (ctDNA) and other biomarkers in the blood, liquid biopsy offers a less invasive alternative to traditional biopsy procedures. Another key advancement is the development of smart capsule endoscopy, which enables wireless monitoring of gut motility and pH levels, providing valuable insights into digestive health without requiring sedation or hospital visits. These innovations are making GI diagnostics more efficient, patient-friendly, and capable of detecting diseases at earlier stages.

What Factors Are Fueling the Growth of the Gastrointestinal Diagnostics Market?

The growth in the gastrointestinal diagnostics market is driven by several factors, including the rising incidence of GI disorders, increasing adoption of advanced imaging technologies, and the shift toward non-invasive diagnostic methods. The global burden of colorectal cancer and inflammatory bowel diseases has led to greater demand for early screening and precision diagnostics. Government initiatives promoting colon cancer screening programs and improved healthcare infrastructure have also contributed to market expansion.

Technological advancements, such as AI-assisted endoscopy, liquid biopsy, and microbiome-based diagnostics, are further accelerating market growth. The increasing preference for home-based and point-of-care testing solutions has expanded patient access to GI diagnostics, particularly in underserved regions. Additionally, the expansion of telemedicine and digital health platforms is enabling remote GI consultations and diagnostic assessments. As healthcare providers continue to emphasize early detection and personalized medicine, the gastrointestinal diagnostics market is expected to experience sustained growth, driven by innovation and rising healthcare awareness.

SCOPE OF STUDY:

The report analyzes the Gastrointestinal Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Test (Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test, Other Gastrointestinal Diagnostics Tests); Technology (ELISA Technology, PCR Technology, Microbiology Technology, Other Technologies); Test Location (Central Laboratories Test Location, Point-of-Care Test Location); Application (Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

  • Abbott Point of Care, Inc.
  • Beckman Coulter, Inc.
  • bioMerieux SA
  • Boston Scientific Corporation
  • DiaSorin SpA
  • Exact Sciences Corporation
  • F. Hoffmann-La Roche Ltd.
  • FUJIFILM Holdings Corporation
  • Genova Diagnostics, Inc.
  • Guardant Health, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Show more
Product Code: MCP31154

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Gastrointestinal Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Global Burden of GI Diseases Drives Demand for Early and Accurate Diagnostic Tools
    • Rising Adoption of Non-Invasive and Minimally Invasive GI Diagnostics Spurs Market Growth
    • Advancements in Endoscopic Imaging Technologies Enhance Detection of Pre-Cancerous and Inflammatory Conditions
    • Surge in Colon Cancer Screening Programs Worldwide Expands Market for Colonoscopy and Sigmoidoscopy Devices
    • Integration of AI and Machine Learning in GI Imaging Tools Improves Diagnostic Accuracy and Workflow
    • Growing Geriatric Population Elevates Demand for Diagnostics in Age-Related GI Conditions
    • Rising Prevalence of Functional GI Disorders Like IBS and IBD Boosts Demand for Advanced Imaging and Lab Tests
    • Adoption of Capsule Endoscopy and Wireless Motility Devices Expands Accessibility in Non-Hospital Settings
    • Pharmaceutical Companies Collaborating with Diagnostic Firms to Improve GI Disease Stratification and Monitoring
    • Increased Consumer Awareness of Digestive Health Drives Demand for Early Symptom Screening
    • Expansion of Diagnostic Labs and Gastro Clinics in Emerging Markets Improves Test Accessibility
    • Government-Led Health Screenings and CRC Programs Strengthen Institutional Demand for GI Diagnostics
    • Rising Use of Biomarkers and Molecular Testing in GI Disease Diagnosis Enhances Clinical Precision
    • OEM Innovation in Disposable Scopes and AI-Guided Colonoscopy Enhances Efficiency and Reduces Risk
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Gastrointestinal Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Gastrointestinal Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Gastrointestinal Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Endoscopy Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Endoscopy Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Endoscopy Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Blood Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Blood Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Blood Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for H. Pylori Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for H. Pylori Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for H. Pylori Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Calprotectin Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Calprotectin Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Calprotectin Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Immunoglobulin Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Immunoglobulin Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Immunoglobulin Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Gastrointestinal Diagnostics Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Gastrointestinal Diagnostics Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Other Gastrointestinal Diagnostics Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for ELISA Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for ELISA Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for ELISA Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for PCR Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for PCR Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for PCR Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Microbiology Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Microbiology Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Microbiology Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Central Laboratories Test Location by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Central Laboratories Test Location by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Central Laboratories Test Location by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Point-of-Care Test Location by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Point-of-Care Test Location by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Point-of-Care Test Location by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Infection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Infection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: World 15-Year Perspective for Infection by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 44: World Recent Past, Current & Future Analysis for Inflammatory Bowel Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: World Historic Review for Inflammatory Bowel Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: World 15-Year Perspective for Inflammatory Bowel Disease Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 47: World Recent Past, Current & Future Analysis for Gastroesophageal Reflux Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 48: World Historic Review for Gastroesophageal Reflux Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: World 15-Year Perspective for Gastroesophageal Reflux Disease Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 50: World Recent Past, Current & Future Analysis for Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 51: World Historic Review for Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: World 15-Year Perspective for Cancer Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 53: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 54: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Gastrointestinal Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 56: USA Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Test - Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: USA Historic Review for Gastrointestinal Diagnostics by Test - Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: USA 15-Year Perspective for Gastrointestinal Diagnostics by Test - Percentage Breakdown of Value Sales for Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests for the Years 2015, 2025 & 2030
    • TABLE 59: USA Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Technology - Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: USA Historic Review for Gastrointestinal Diagnostics by Technology - Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: USA 15-Year Perspective for Gastrointestinal Diagnostics by Technology - Percentage Breakdown of Value Sales for Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology for the Years 2015, 2025 & 2030
    • TABLE 62: USA Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Test Location - Central Laboratories Test Location and Point-of-Care Test Location - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: USA Historic Review for Gastrointestinal Diagnostics by Test Location - Central Laboratories Test Location and Point-of-Care Test Location Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: USA 15-Year Perspective for Gastrointestinal Diagnostics by Test Location - Percentage Breakdown of Value Sales for Central Laboratories Test Location and Point-of-Care Test Location for the Years 2015, 2025 & 2030
    • TABLE 65: USA Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Application - Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: USA Historic Review for Gastrointestinal Diagnostics by Application - Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: USA 15-Year Perspective for Gastrointestinal Diagnostics by Application - Percentage Breakdown of Value Sales for Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 68: Canada Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Test - Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Canada Historic Review for Gastrointestinal Diagnostics by Test - Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Canada 15-Year Perspective for Gastrointestinal Diagnostics by Test - Percentage Breakdown of Value Sales for Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests for the Years 2015, 2025 & 2030
    • TABLE 71: Canada Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Technology - Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Canada Historic Review for Gastrointestinal Diagnostics by Technology - Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Canada 15-Year Perspective for Gastrointestinal Diagnostics by Technology - Percentage Breakdown of Value Sales for Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology for the Years 2015, 2025 & 2030
    • TABLE 74: Canada Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Test Location - Central Laboratories Test Location and Point-of-Care Test Location - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Canada Historic Review for Gastrointestinal Diagnostics by Test Location - Central Laboratories Test Location and Point-of-Care Test Location Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Canada 15-Year Perspective for Gastrointestinal Diagnostics by Test Location - Percentage Breakdown of Value Sales for Central Laboratories Test Location and Point-of-Care Test Location for the Years 2015, 2025 & 2030
    • TABLE 77: Canada Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Application - Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Canada Historic Review for Gastrointestinal Diagnostics by Application - Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Canada 15-Year Perspective for Gastrointestinal Diagnostics by Application - Percentage Breakdown of Value Sales for Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • Gastrointestinal Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 80: Japan Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Test - Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Japan Historic Review for Gastrointestinal Diagnostics by Test - Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Japan 15-Year Perspective for Gastrointestinal Diagnostics by Test - Percentage Breakdown of Value Sales for Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests for the Years 2015, 2025 & 2030
    • TABLE 83: Japan Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Technology - Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Japan Historic Review for Gastrointestinal Diagnostics by Technology - Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Japan 15-Year Perspective for Gastrointestinal Diagnostics by Technology - Percentage Breakdown of Value Sales for Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology for the Years 2015, 2025 & 2030
    • TABLE 86: Japan Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Test Location - Central Laboratories Test Location and Point-of-Care Test Location - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Japan Historic Review for Gastrointestinal Diagnostics by Test Location - Central Laboratories Test Location and Point-of-Care Test Location Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Japan 15-Year Perspective for Gastrointestinal Diagnostics by Test Location - Percentage Breakdown of Value Sales for Central Laboratories Test Location and Point-of-Care Test Location for the Years 2015, 2025 & 2030
    • TABLE 89: Japan Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Application - Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Japan Historic Review for Gastrointestinal Diagnostics by Application - Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Japan 15-Year Perspective for Gastrointestinal Diagnostics by Application - Percentage Breakdown of Value Sales for Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • Gastrointestinal Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 92: China Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Test - Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: China Historic Review for Gastrointestinal Diagnostics by Test - Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: China 15-Year Perspective for Gastrointestinal Diagnostics by Test - Percentage Breakdown of Value Sales for Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests for the Years 2015, 2025 & 2030
    • TABLE 95: China Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Technology - Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: China Historic Review for Gastrointestinal Diagnostics by Technology - Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: China 15-Year Perspective for Gastrointestinal Diagnostics by Technology - Percentage Breakdown of Value Sales for Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology for the Years 2015, 2025 & 2030
    • TABLE 98: China Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Test Location - Central Laboratories Test Location and Point-of-Care Test Location - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: China Historic Review for Gastrointestinal Diagnostics by Test Location - Central Laboratories Test Location and Point-of-Care Test Location Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: China 15-Year Perspective for Gastrointestinal Diagnostics by Test Location - Percentage Breakdown of Value Sales for Central Laboratories Test Location and Point-of-Care Test Location for the Years 2015, 2025 & 2030
    • TABLE 101: China Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Application - Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: China Historic Review for Gastrointestinal Diagnostics by Application - Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: China 15-Year Perspective for Gastrointestinal Diagnostics by Application - Percentage Breakdown of Value Sales for Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • Gastrointestinal Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 104: Europe Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 105: Europe Historic Review for Gastrointestinal Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Europe 15-Year Perspective for Gastrointestinal Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 107: Europe Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Test - Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Europe Historic Review for Gastrointestinal Diagnostics by Test - Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Europe 15-Year Perspective for Gastrointestinal Diagnostics by Test - Percentage Breakdown of Value Sales for Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests for the Years 2015, 2025 & 2030
    • TABLE 110: Europe Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Technology - Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Europe Historic Review for Gastrointestinal Diagnostics by Technology - Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Europe 15-Year Perspective for Gastrointestinal Diagnostics by Technology - Percentage Breakdown of Value Sales for Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology for the Years 2015, 2025 & 2030
    • TABLE 113: Europe Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Test Location - Central Laboratories Test Location and Point-of-Care Test Location - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Europe Historic Review for Gastrointestinal Diagnostics by Test Location - Central Laboratories Test Location and Point-of-Care Test Location Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Europe 15-Year Perspective for Gastrointestinal Diagnostics by Test Location - Percentage Breakdown of Value Sales for Central Laboratories Test Location and Point-of-Care Test Location for the Years 2015, 2025 & 2030
    • TABLE 116: Europe Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Application - Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Europe Historic Review for Gastrointestinal Diagnostics by Application - Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Europe 15-Year Perspective for Gastrointestinal Diagnostics by Application - Percentage Breakdown of Value Sales for Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications for the Years 2015, 2025 & 2030
  • FRANCE
    • Gastrointestinal Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 119: France Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Test - Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: France Historic Review for Gastrointestinal Diagnostics by Test - Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: France 15-Year Perspective for Gastrointestinal Diagnostics by Test - Percentage Breakdown of Value Sales for Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests for the Years 2015, 2025 & 2030
    • TABLE 122: France Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Technology - Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: France Historic Review for Gastrointestinal Diagnostics by Technology - Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: France 15-Year Perspective for Gastrointestinal Diagnostics by Technology - Percentage Breakdown of Value Sales for Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology for the Years 2015, 2025 & 2030
    • TABLE 125: France Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Test Location - Central Laboratories Test Location and Point-of-Care Test Location - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: France Historic Review for Gastrointestinal Diagnostics by Test Location - Central Laboratories Test Location and Point-of-Care Test Location Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: France 15-Year Perspective for Gastrointestinal Diagnostics by Test Location - Percentage Breakdown of Value Sales for Central Laboratories Test Location and Point-of-Care Test Location for the Years 2015, 2025 & 2030
    • TABLE 128: France Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Application - Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: France Historic Review for Gastrointestinal Diagnostics by Application - Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: France 15-Year Perspective for Gastrointestinal Diagnostics by Application - Percentage Breakdown of Value Sales for Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • Gastrointestinal Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 131: Germany Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Test - Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Germany Historic Review for Gastrointestinal Diagnostics by Test - Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Germany 15-Year Perspective for Gastrointestinal Diagnostics by Test - Percentage Breakdown of Value Sales for Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests for the Years 2015, 2025 & 2030
    • TABLE 134: Germany Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Technology - Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Germany Historic Review for Gastrointestinal Diagnostics by Technology - Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Germany 15-Year Perspective for Gastrointestinal Diagnostics by Technology - Percentage Breakdown of Value Sales for Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology for the Years 2015, 2025 & 2030
    • TABLE 137: Germany Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Test Location - Central Laboratories Test Location and Point-of-Care Test Location - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Germany Historic Review for Gastrointestinal Diagnostics by Test Location - Central Laboratories Test Location and Point-of-Care Test Location Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Germany 15-Year Perspective for Gastrointestinal Diagnostics by Test Location - Percentage Breakdown of Value Sales for Central Laboratories Test Location and Point-of-Care Test Location for the Years 2015, 2025 & 2030
    • TABLE 140: Germany Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Application - Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Germany Historic Review for Gastrointestinal Diagnostics by Application - Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Germany 15-Year Perspective for Gastrointestinal Diagnostics by Application - Percentage Breakdown of Value Sales for Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 143: Italy Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Test - Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Italy Historic Review for Gastrointestinal Diagnostics by Test - Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Italy 15-Year Perspective for Gastrointestinal Diagnostics by Test - Percentage Breakdown of Value Sales for Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests for the Years 2015, 2025 & 2030
    • TABLE 146: Italy Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Technology - Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Italy Historic Review for Gastrointestinal Diagnostics by Technology - Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Italy 15-Year Perspective for Gastrointestinal Diagnostics by Technology - Percentage Breakdown of Value Sales for Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology for the Years 2015, 2025 & 2030
    • TABLE 149: Italy Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Test Location - Central Laboratories Test Location and Point-of-Care Test Location - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Italy Historic Review for Gastrointestinal Diagnostics by Test Location - Central Laboratories Test Location and Point-of-Care Test Location Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Italy 15-Year Perspective for Gastrointestinal Diagnostics by Test Location - Percentage Breakdown of Value Sales for Central Laboratories Test Location and Point-of-Care Test Location for the Years 2015, 2025 & 2030
    • TABLE 152: Italy Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Application - Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Italy Historic Review for Gastrointestinal Diagnostics by Application - Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Italy 15-Year Perspective for Gastrointestinal Diagnostics by Application - Percentage Breakdown of Value Sales for Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Gastrointestinal Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 155: UK Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Test - Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: UK Historic Review for Gastrointestinal Diagnostics by Test - Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: UK 15-Year Perspective for Gastrointestinal Diagnostics by Test - Percentage Breakdown of Value Sales for Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests for the Years 2015, 2025 & 2030
    • TABLE 158: UK Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Technology - Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: UK Historic Review for Gastrointestinal Diagnostics by Technology - Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: UK 15-Year Perspective for Gastrointestinal Diagnostics by Technology - Percentage Breakdown of Value Sales for Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology for the Years 2015, 2025 & 2030
    • TABLE 161: UK Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Test Location - Central Laboratories Test Location and Point-of-Care Test Location - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: UK Historic Review for Gastrointestinal Diagnostics by Test Location - Central Laboratories Test Location and Point-of-Care Test Location Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: UK 15-Year Perspective for Gastrointestinal Diagnostics by Test Location - Percentage Breakdown of Value Sales for Central Laboratories Test Location and Point-of-Care Test Location for the Years 2015, 2025 & 2030
    • TABLE 164: UK Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Application - Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: UK Historic Review for Gastrointestinal Diagnostics by Application - Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: UK 15-Year Perspective for Gastrointestinal Diagnostics by Application - Percentage Breakdown of Value Sales for Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 167: Spain Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Test - Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Spain Historic Review for Gastrointestinal Diagnostics by Test - Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Spain 15-Year Perspective for Gastrointestinal Diagnostics by Test - Percentage Breakdown of Value Sales for Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests for the Years 2015, 2025 & 2030
    • TABLE 170: Spain Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Technology - Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Spain Historic Review for Gastrointestinal Diagnostics by Technology - Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Spain 15-Year Perspective for Gastrointestinal Diagnostics by Technology - Percentage Breakdown of Value Sales for Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology for the Years 2015, 2025 & 2030
    • TABLE 173: Spain Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Test Location - Central Laboratories Test Location and Point-of-Care Test Location - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Spain Historic Review for Gastrointestinal Diagnostics by Test Location - Central Laboratories Test Location and Point-of-Care Test Location Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Spain 15-Year Perspective for Gastrointestinal Diagnostics by Test Location - Percentage Breakdown of Value Sales for Central Laboratories Test Location and Point-of-Care Test Location for the Years 2015, 2025 & 2030
    • TABLE 176: Spain Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Application - Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Spain Historic Review for Gastrointestinal Diagnostics by Application - Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Spain 15-Year Perspective for Gastrointestinal Diagnostics by Application - Percentage Breakdown of Value Sales for Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 179: Russia Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Test - Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Russia Historic Review for Gastrointestinal Diagnostics by Test - Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Russia 15-Year Perspective for Gastrointestinal Diagnostics by Test - Percentage Breakdown of Value Sales for Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests for the Years 2015, 2025 & 2030
    • TABLE 182: Russia Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Technology - Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Russia Historic Review for Gastrointestinal Diagnostics by Technology - Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Russia 15-Year Perspective for Gastrointestinal Diagnostics by Technology - Percentage Breakdown of Value Sales for Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology for the Years 2015, 2025 & 2030
    • TABLE 185: Russia Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Test Location - Central Laboratories Test Location and Point-of-Care Test Location - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Russia Historic Review for Gastrointestinal Diagnostics by Test Location - Central Laboratories Test Location and Point-of-Care Test Location Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Russia 15-Year Perspective for Gastrointestinal Diagnostics by Test Location - Percentage Breakdown of Value Sales for Central Laboratories Test Location and Point-of-Care Test Location for the Years 2015, 2025 & 2030
    • TABLE 188: Russia Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Application - Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Russia Historic Review for Gastrointestinal Diagnostics by Application - Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Russia 15-Year Perspective for Gastrointestinal Diagnostics by Application - Percentage Breakdown of Value Sales for Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 191: Rest of Europe Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Test - Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Europe Historic Review for Gastrointestinal Diagnostics by Test - Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Europe 15-Year Perspective for Gastrointestinal Diagnostics by Test - Percentage Breakdown of Value Sales for Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests for the Years 2015, 2025 & 2030
    • TABLE 194: Rest of Europe Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Technology - Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Europe Historic Review for Gastrointestinal Diagnostics by Technology - Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Europe 15-Year Perspective for Gastrointestinal Diagnostics by Technology - Percentage Breakdown of Value Sales for Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology for the Years 2015, 2025 & 2030
    • TABLE 197: Rest of Europe Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Test Location - Central Laboratories Test Location and Point-of-Care Test Location - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Europe Historic Review for Gastrointestinal Diagnostics by Test Location - Central Laboratories Test Location and Point-of-Care Test Location Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Europe 15-Year Perspective for Gastrointestinal Diagnostics by Test Location - Percentage Breakdown of Value Sales for Central Laboratories Test Location and Point-of-Care Test Location for the Years 2015, 2025 & 2030
    • TABLE 200: Rest of Europe Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Application - Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Europe Historic Review for Gastrointestinal Diagnostics by Application - Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Europe 15-Year Perspective for Gastrointestinal Diagnostics by Application - Percentage Breakdown of Value Sales for Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Gastrointestinal Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 203: Asia-Pacific Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 204: Asia-Pacific Historic Review for Gastrointestinal Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Asia-Pacific 15-Year Perspective for Gastrointestinal Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 206: Asia-Pacific Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Test - Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Asia-Pacific Historic Review for Gastrointestinal Diagnostics by Test - Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Asia-Pacific 15-Year Perspective for Gastrointestinal Diagnostics by Test - Percentage Breakdown of Value Sales for Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests for the Years 2015, 2025 & 2030
    • TABLE 209: Asia-Pacific Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Technology - Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Asia-Pacific Historic Review for Gastrointestinal Diagnostics by Technology - Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Asia-Pacific 15-Year Perspective for Gastrointestinal Diagnostics by Technology - Percentage Breakdown of Value Sales for Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology for the Years 2015, 2025 & 2030
    • TABLE 212: Asia-Pacific Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Test Location - Central Laboratories Test Location and Point-of-Care Test Location - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Asia-Pacific Historic Review for Gastrointestinal Diagnostics by Test Location - Central Laboratories Test Location and Point-of-Care Test Location Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Asia-Pacific 15-Year Perspective for Gastrointestinal Diagnostics by Test Location - Percentage Breakdown of Value Sales for Central Laboratories Test Location and Point-of-Care Test Location for the Years 2015, 2025 & 2030
    • TABLE 215: Asia-Pacific Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Application - Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Asia-Pacific Historic Review for Gastrointestinal Diagnostics by Application - Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Asia-Pacific 15-Year Perspective for Gastrointestinal Diagnostics by Application - Percentage Breakdown of Value Sales for Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Gastrointestinal Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 218: Australia Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Test - Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Australia Historic Review for Gastrointestinal Diagnostics by Test - Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Australia 15-Year Perspective for Gastrointestinal Diagnostics by Test - Percentage Breakdown of Value Sales for Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests for the Years 2015, 2025 & 2030
    • TABLE 221: Australia Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Technology - Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Australia Historic Review for Gastrointestinal Diagnostics by Technology - Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: Australia 15-Year Perspective for Gastrointestinal Diagnostics by Technology - Percentage Breakdown of Value Sales for Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology for the Years 2015, 2025 & 2030
    • TABLE 224: Australia Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Test Location - Central Laboratories Test Location and Point-of-Care Test Location - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Australia Historic Review for Gastrointestinal Diagnostics by Test Location - Central Laboratories Test Location and Point-of-Care Test Location Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: Australia 15-Year Perspective for Gastrointestinal Diagnostics by Test Location - Percentage Breakdown of Value Sales for Central Laboratories Test Location and Point-of-Care Test Location for the Years 2015, 2025 & 2030
    • TABLE 227: Australia Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Application - Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Australia Historic Review for Gastrointestinal Diagnostics by Application - Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: Australia 15-Year Perspective for Gastrointestinal Diagnostics by Application - Percentage Breakdown of Value Sales for Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications for the Years 2015, 2025 & 2030
  • INDIA
    • Gastrointestinal Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 230: India Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Test - Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: India Historic Review for Gastrointestinal Diagnostics by Test - Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: India 15-Year Perspective for Gastrointestinal Diagnostics by Test - Percentage Breakdown of Value Sales for Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests for the Years 2015, 2025 & 2030
    • TABLE 233: India Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Technology - Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: India Historic Review for Gastrointestinal Diagnostics by Technology - Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 235: India 15-Year Perspective for Gastrointestinal Diagnostics by Technology - Percentage Breakdown of Value Sales for Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology for the Years 2015, 2025 & 2030
    • TABLE 236: India Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Test Location - Central Laboratories Test Location and Point-of-Care Test Location - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: India Historic Review for Gastrointestinal Diagnostics by Test Location - Central Laboratories Test Location and Point-of-Care Test Location Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 238: India 15-Year Perspective for Gastrointestinal Diagnostics by Test Location - Percentage Breakdown of Value Sales for Central Laboratories Test Location and Point-of-Care Test Location for the Years 2015, 2025 & 2030
    • TABLE 239: India Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Application - Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: India Historic Review for Gastrointestinal Diagnostics by Application - Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 241: India 15-Year Perspective for Gastrointestinal Diagnostics by Application - Percentage Breakdown of Value Sales for Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 242: South Korea Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Test - Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: South Korea Historic Review for Gastrointestinal Diagnostics by Test - Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 244: South Korea 15-Year Perspective for Gastrointestinal Diagnostics by Test - Percentage Breakdown of Value Sales for Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests for the Years 2015, 2025 & 2030
    • TABLE 245: South Korea Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Technology - Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: South Korea Historic Review for Gastrointestinal Diagnostics by Technology - Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 247: South Korea 15-Year Perspective for Gastrointestinal Diagnostics by Technology - Percentage Breakdown of Value Sales for Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology for the Years 2015, 2025 & 2030
    • TABLE 248: South Korea Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Test Location - Central Laboratories Test Location and Point-of-Care Test Location - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: South Korea Historic Review for Gastrointestinal Diagnostics by Test Location - Central Laboratories Test Location and Point-of-Care Test Location Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 250: South Korea 15-Year Perspective for Gastrointestinal Diagnostics by Test Location - Percentage Breakdown of Value Sales for Central Laboratories Test Location and Point-of-Care Test Location for the Years 2015, 2025 & 2030
    • TABLE 251: South Korea Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Application - Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: South Korea Historic Review for Gastrointestinal Diagnostics by Application - Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 253: South Korea 15-Year Perspective for Gastrointestinal Diagnostics by Application - Percentage Breakdown of Value Sales for Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 254: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Test - Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Rest of Asia-Pacific Historic Review for Gastrointestinal Diagnostics by Test - Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 256: Rest of Asia-Pacific 15-Year Perspective for Gastrointestinal Diagnostics by Test - Percentage Breakdown of Value Sales for Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests for the Years 2015, 2025 & 2030
    • TABLE 257: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Technology - Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Rest of Asia-Pacific Historic Review for Gastrointestinal Diagnostics by Technology - Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 259: Rest of Asia-Pacific 15-Year Perspective for Gastrointestinal Diagnostics by Technology - Percentage Breakdown of Value Sales for Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology for the Years 2015, 2025 & 2030
    • TABLE 260: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Test Location - Central Laboratories Test Location and Point-of-Care Test Location - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Rest of Asia-Pacific Historic Review for Gastrointestinal Diagnostics by Test Location - Central Laboratories Test Location and Point-of-Care Test Location Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 262: Rest of Asia-Pacific 15-Year Perspective for Gastrointestinal Diagnostics by Test Location - Percentage Breakdown of Value Sales for Central Laboratories Test Location and Point-of-Care Test Location for the Years 2015, 2025 & 2030
    • TABLE 263: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Application - Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Rest of Asia-Pacific Historic Review for Gastrointestinal Diagnostics by Application - Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 265: Rest of Asia-Pacific 15-Year Perspective for Gastrointestinal Diagnostics by Application - Percentage Breakdown of Value Sales for Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Gastrointestinal Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 266: Latin America Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 267: Latin America Historic Review for Gastrointestinal Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 268: Latin America 15-Year Perspective for Gastrointestinal Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 269: Latin America Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Test - Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Latin America Historic Review for Gastrointestinal Diagnostics by Test - Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 271: Latin America 15-Year Perspective for Gastrointestinal Diagnostics by Test - Percentage Breakdown of Value Sales for Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests for the Years 2015, 2025 & 2030
    • TABLE 272: Latin America Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Technology - Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Latin America Historic Review for Gastrointestinal Diagnostics by Technology - Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 274: Latin America 15-Year Perspective for Gastrointestinal Diagnostics by Technology - Percentage Breakdown of Value Sales for Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology for the Years 2015, 2025 & 2030
    • TABLE 275: Latin America Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Test Location - Central Laboratories Test Location and Point-of-Care Test Location - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Latin America Historic Review for Gastrointestinal Diagnostics by Test Location - Central Laboratories Test Location and Point-of-Care Test Location Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 277: Latin America 15-Year Perspective for Gastrointestinal Diagnostics by Test Location - Percentage Breakdown of Value Sales for Central Laboratories Test Location and Point-of-Care Test Location for the Years 2015, 2025 & 2030
    • TABLE 278: Latin America Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Application - Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Latin America Historic Review for Gastrointestinal Diagnostics by Application - Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 280: Latin America 15-Year Perspective for Gastrointestinal Diagnostics by Application - Percentage Breakdown of Value Sales for Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 281: Argentina Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Test - Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Argentina Historic Review for Gastrointestinal Diagnostics by Test - Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 283: Argentina 15-Year Perspective for Gastrointestinal Diagnostics by Test - Percentage Breakdown of Value Sales for Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests for the Years 2015, 2025 & 2030
    • TABLE 284: Argentina Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Technology - Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Argentina Historic Review for Gastrointestinal Diagnostics by Technology - Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 286: Argentina 15-Year Perspective for Gastrointestinal Diagnostics by Technology - Percentage Breakdown of Value Sales for Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology for the Years 2015, 2025 & 2030
    • TABLE 287: Argentina Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Test Location - Central Laboratories Test Location and Point-of-Care Test Location - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Argentina Historic Review for Gastrointestinal Diagnostics by Test Location - Central Laboratories Test Location and Point-of-Care Test Location Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 289: Argentina 15-Year Perspective for Gastrointestinal Diagnostics by Test Location - Percentage Breakdown of Value Sales for Central Laboratories Test Location and Point-of-Care Test Location for the Years 2015, 2025 & 2030
    • TABLE 290: Argentina Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Application - Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Argentina Historic Review for Gastrointestinal Diagnostics by Application - Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 292: Argentina 15-Year Perspective for Gastrointestinal Diagnostics by Application - Percentage Breakdown of Value Sales for Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 293: Brazil Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Test - Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Brazil Historic Review for Gastrointestinal Diagnostics by Test - Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 295: Brazil 15-Year Perspective for Gastrointestinal Diagnostics by Test - Percentage Breakdown of Value Sales for Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests for the Years 2015, 2025 & 2030
    • TABLE 296: Brazil Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Technology - Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Brazil Historic Review for Gastrointestinal Diagnostics by Technology - Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 298: Brazil 15-Year Perspective for Gastrointestinal Diagnostics by Technology - Percentage Breakdown of Value Sales for Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology for the Years 2015, 2025 & 2030
    • TABLE 299: Brazil Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Test Location - Central Laboratories Test Location and Point-of-Care Test Location - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Brazil Historic Review for Gastrointestinal Diagnostics by Test Location - Central Laboratories Test Location and Point-of-Care Test Location Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 301: Brazil 15-Year Perspective for Gastrointestinal Diagnostics by Test Location - Percentage Breakdown of Value Sales for Central Laboratories Test Location and Point-of-Care Test Location for the Years 2015, 2025 & 2030
    • TABLE 302: Brazil Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Application - Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Brazil Historic Review for Gastrointestinal Diagnostics by Application - Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 304: Brazil 15-Year Perspective for Gastrointestinal Diagnostics by Application - Percentage Breakdown of Value Sales for Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 305: Mexico Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Test - Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Mexico Historic Review for Gastrointestinal Diagnostics by Test - Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 307: Mexico 15-Year Perspective for Gastrointestinal Diagnostics by Test - Percentage Breakdown of Value Sales for Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests for the Years 2015, 2025 & 2030
    • TABLE 308: Mexico Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Technology - Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Mexico Historic Review for Gastrointestinal Diagnostics by Technology - Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 310: Mexico 15-Year Perspective for Gastrointestinal Diagnostics by Technology - Percentage Breakdown of Value Sales for Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology for the Years 2015, 2025 & 2030
    • TABLE 311: Mexico Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Test Location - Central Laboratories Test Location and Point-of-Care Test Location - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Mexico Historic Review for Gastrointestinal Diagnostics by Test Location - Central Laboratories Test Location and Point-of-Care Test Location Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 313: Mexico 15-Year Perspective for Gastrointestinal Diagnostics by Test Location - Percentage Breakdown of Value Sales for Central Laboratories Test Location and Point-of-Care Test Location for the Years 2015, 2025 & 2030
    • TABLE 314: Mexico Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Application - Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 315: Mexico Historic Review for Gastrointestinal Diagnostics by Application - Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 316: Mexico 15-Year Perspective for Gastrointestinal Diagnostics by Application - Percentage Breakdown of Value Sales for Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 317: Rest of Latin America Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Test - Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 318: Rest of Latin America Historic Review for Gastrointestinal Diagnostics by Test - Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 319: Rest of Latin America 15-Year Perspective for Gastrointestinal Diagnostics by Test - Percentage Breakdown of Value Sales for Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests for the Years 2015, 2025 & 2030
    • TABLE 320: Rest of Latin America Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Technology - Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 321: Rest of Latin America Historic Review for Gastrointestinal Diagnostics by Technology - Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 322: Rest of Latin America 15-Year Perspective for Gastrointestinal Diagnostics by Technology - Percentage Breakdown of Value Sales for Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology for the Years 2015, 2025 & 2030
    • TABLE 323: Rest of Latin America Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Test Location - Central Laboratories Test Location and Point-of-Care Test Location - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 324: Rest of Latin America Historic Review for Gastrointestinal Diagnostics by Test Location - Central Laboratories Test Location and Point-of-Care Test Location Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 325: Rest of Latin America 15-Year Perspective for Gastrointestinal Diagnostics by Test Location - Percentage Breakdown of Value Sales for Central Laboratories Test Location and Point-of-Care Test Location for the Years 2015, 2025 & 2030
    • TABLE 326: Rest of Latin America Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Application - Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 327: Rest of Latin America Historic Review for Gastrointestinal Diagnostics by Application - Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 328: Rest of Latin America 15-Year Perspective for Gastrointestinal Diagnostics by Application - Percentage Breakdown of Value Sales for Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Gastrointestinal Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 329: Middle East Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 330: Middle East Historic Review for Gastrointestinal Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 331: Middle East 15-Year Perspective for Gastrointestinal Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 332: Middle East Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Test - Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 333: Middle East Historic Review for Gastrointestinal Diagnostics by Test - Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 334: Middle East 15-Year Perspective for Gastrointestinal Diagnostics by Test - Percentage Breakdown of Value Sales for Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests for the Years 2015, 2025 & 2030
    • TABLE 335: Middle East Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Technology - Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 336: Middle East Historic Review for Gastrointestinal Diagnostics by Technology - Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 337: Middle East 15-Year Perspective for Gastrointestinal Diagnostics by Technology - Percentage Breakdown of Value Sales for Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology for the Years 2015, 2025 & 2030
    • TABLE 338: Middle East Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Test Location - Central Laboratories Test Location and Point-of-Care Test Location - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 339: Middle East Historic Review for Gastrointestinal Diagnostics by Test Location - Central Laboratories Test Location and Point-of-Care Test Location Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 340: Middle East 15-Year Perspective for Gastrointestinal Diagnostics by Test Location - Percentage Breakdown of Value Sales for Central Laboratories Test Location and Point-of-Care Test Location for the Years 2015, 2025 & 2030
    • TABLE 341: Middle East Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Application - Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 342: Middle East Historic Review for Gastrointestinal Diagnostics by Application - Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 343: Middle East 15-Year Perspective for Gastrointestinal Diagnostics by Application - Percentage Breakdown of Value Sales for Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 344: Iran Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Test - Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 345: Iran Historic Review for Gastrointestinal Diagnostics by Test - Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 346: Iran 15-Year Perspective for Gastrointestinal Diagnostics by Test - Percentage Breakdown of Value Sales for Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests for the Years 2015, 2025 & 2030
    • TABLE 347: Iran Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Technology - Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 348: Iran Historic Review for Gastrointestinal Diagnostics by Technology - Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 349: Iran 15-Year Perspective for Gastrointestinal Diagnostics by Technology - Percentage Breakdown of Value Sales for Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology for the Years 2015, 2025 & 2030
    • TABLE 350: Iran Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Test Location - Central Laboratories Test Location and Point-of-Care Test Location - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 351: Iran Historic Review for Gastrointestinal Diagnostics by Test Location - Central Laboratories Test Location and Point-of-Care Test Location Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 352: Iran 15-Year Perspective for Gastrointestinal Diagnostics by Test Location - Percentage Breakdown of Value Sales for Central Laboratories Test Location and Point-of-Care Test Location for the Years 2015, 2025 & 2030
    • TABLE 353: Iran Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Application - Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 354: Iran Historic Review for Gastrointestinal Diagnostics by Application - Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 355: Iran 15-Year Perspective for Gastrointestinal Diagnostics by Application - Percentage Breakdown of Value Sales for Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 356: Israel Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Test - Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 357: Israel Historic Review for Gastrointestinal Diagnostics by Test - Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 358: Israel 15-Year Perspective for Gastrointestinal Diagnostics by Test - Percentage Breakdown of Value Sales for Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests for the Years 2015, 2025 & 2030
    • TABLE 359: Israel Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Technology - Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 360: Israel Historic Review for Gastrointestinal Diagnostics by Technology - Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 361: Israel 15-Year Perspective for Gastrointestinal Diagnostics by Technology - Percentage Breakdown of Value Sales for Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology for the Years 2015, 2025 & 2030
    • TABLE 362: Israel Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Test Location - Central Laboratories Test Location and Point-of-Care Test Location - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 363: Israel Historic Review for Gastrointestinal Diagnostics by Test Location - Central Laboratories Test Location and Point-of-Care Test Location Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 364: Israel 15-Year Perspective for Gastrointestinal Diagnostics by Test Location - Percentage Breakdown of Value Sales for Central Laboratories Test Location and Point-of-Care Test Location for the Years 2015, 2025 & 2030
    • TABLE 365: Israel Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Application - Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 366: Israel Historic Review for Gastrointestinal Diagnostics by Application - Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 367: Israel 15-Year Perspective for Gastrointestinal Diagnostics by Application - Percentage Breakdown of Value Sales for Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 368: Saudi Arabia Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Test - Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 369: Saudi Arabia Historic Review for Gastrointestinal Diagnostics by Test - Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 370: Saudi Arabia 15-Year Perspective for Gastrointestinal Diagnostics by Test - Percentage Breakdown of Value Sales for Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests for the Years 2015, 2025 & 2030
    • TABLE 371: Saudi Arabia Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Technology - Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 372: Saudi Arabia Historic Review for Gastrointestinal Diagnostics by Technology - Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 373: Saudi Arabia 15-Year Perspective for Gastrointestinal Diagnostics by Technology - Percentage Breakdown of Value Sales for Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology for the Years 2015, 2025 & 2030
    • TABLE 374: Saudi Arabia Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Test Location - Central Laboratories Test Location and Point-of-Care Test Location - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 375: Saudi Arabia Historic Review for Gastrointestinal Diagnostics by Test Location - Central Laboratories Test Location and Point-of-Care Test Location Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 376: Saudi Arabia 15-Year Perspective for Gastrointestinal Diagnostics by Test Location - Percentage Breakdown of Value Sales for Central Laboratories Test Location and Point-of-Care Test Location for the Years 2015, 2025 & 2030
    • TABLE 377: Saudi Arabia Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Application - Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 378: Saudi Arabia Historic Review for Gastrointestinal Diagnostics by Application - Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 379: Saudi Arabia 15-Year Perspective for Gastrointestinal Diagnostics by Application - Percentage Breakdown of Value Sales for Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 380: UAE Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Test - Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 381: UAE Historic Review for Gastrointestinal Diagnostics by Test - Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 382: UAE 15-Year Perspective for Gastrointestinal Diagnostics by Test - Percentage Breakdown of Value Sales for Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests for the Years 2015, 2025 & 2030
    • TABLE 383: UAE Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Technology - Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 384: UAE Historic Review for Gastrointestinal Diagnostics by Technology - Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 385: UAE 15-Year Perspective for Gastrointestinal Diagnostics by Technology - Percentage Breakdown of Value Sales for Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology for the Years 2015, 2025 & 2030
    • TABLE 386: UAE Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Test Location - Central Laboratories Test Location and Point-of-Care Test Location - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 387: UAE Historic Review for Gastrointestinal Diagnostics by Test Location - Central Laboratories Test Location and Point-of-Care Test Location Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 388: UAE 15-Year Perspective for Gastrointestinal Diagnostics by Test Location - Percentage Breakdown of Value Sales for Central Laboratories Test Location and Point-of-Care Test Location for the Years 2015, 2025 & 2030
    • TABLE 389: UAE Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Application - Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 390: UAE Historic Review for Gastrointestinal Diagnostics by Application - Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 391: UAE 15-Year Perspective for Gastrointestinal Diagnostics by Application - Percentage Breakdown of Value Sales for Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 392: Rest of Middle East Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Test - Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 393: Rest of Middle East Historic Review for Gastrointestinal Diagnostics by Test - Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 394: Rest of Middle East 15-Year Perspective for Gastrointestinal Diagnostics by Test - Percentage Breakdown of Value Sales for Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests for the Years 2015, 2025 & 2030
    • TABLE 395: Rest of Middle East Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Technology - Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 396: Rest of Middle East Historic Review for Gastrointestinal Diagnostics by Technology - Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 397: Rest of Middle East 15-Year Perspective for Gastrointestinal Diagnostics by Technology - Percentage Breakdown of Value Sales for Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology for the Years 2015, 2025 & 2030
    • TABLE 398: Rest of Middle East Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Test Location - Central Laboratories Test Location and Point-of-Care Test Location - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 399: Rest of Middle East Historic Review for Gastrointestinal Diagnostics by Test Location - Central Laboratories Test Location and Point-of-Care Test Location Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 400: Rest of Middle East 15-Year Perspective for Gastrointestinal Diagnostics by Test Location - Percentage Breakdown of Value Sales for Central Laboratories Test Location and Point-of-Care Test Location for the Years 2015, 2025 & 2030
    • TABLE 401: Rest of Middle East Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Application - Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 402: Rest of Middle East Historic Review for Gastrointestinal Diagnostics by Application - Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 403: Rest of Middle East 15-Year Perspective for Gastrointestinal Diagnostics by Application - Percentage Breakdown of Value Sales for Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications for the Years 2015, 2025 & 2030
  • AFRICA
    • Gastrointestinal Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 404: Africa Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Test - Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 405: Africa Historic Review for Gastrointestinal Diagnostics by Test - Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 406: Africa 15-Year Perspective for Gastrointestinal Diagnostics by Test - Percentage Breakdown of Value Sales for Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test and Other Gastrointestinal Diagnostics Tests for the Years 2015, 2025 & 2030
    • TABLE 407: Africa Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Technology - Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 408: Africa Historic Review for Gastrointestinal Diagnostics by Technology - Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 409: Africa 15-Year Perspective for Gastrointestinal Diagnostics by Technology - Percentage Breakdown of Value Sales for Other Technologies, ELISA Technology, PCR Technology and Microbiology Technology for the Years 2015, 2025 & 2030
    • TABLE 410: Africa Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Test Location - Central Laboratories Test Location and Point-of-Care Test Location - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 411: Africa Historic Review for Gastrointestinal Diagnostics by Test Location - Central Laboratories Test Location and Point-of-Care Test Location Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 412: Africa 15-Year Perspective for Gastrointestinal Diagnostics by Test Location - Percentage Breakdown of Value Sales for Central Laboratories Test Location and Point-of-Care Test Location for the Years 2015, 2025 & 2030
    • TABLE 413: Africa Recent Past, Current & Future Analysis for Gastrointestinal Diagnostics by Application - Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 414: Africa Historic Review for Gastrointestinal Diagnostics by Application - Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 415: Africa 15-Year Perspective for Gastrointestinal Diagnostics by Application - Percentage Breakdown of Value Sales for Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!